Samsung Medical Center Improves Survival Rate of Liver Cancer through Multidisciplinary Team Approach

Last updated date: 18-Jul-2021

General HealthLiver CancerSamsung Medical Center
Samsung Medical Center

1 mins read


Samsung Medical Center research team revealed that it has analyzed the survival rate of 6,619 patients, who were newly diagnosed with liver cancer between 2005 and 2013, and found that a 5-year survival rate of patients who received multidisciplinary treatment was 71.2%, which was higher than 49.4% survival rate of patients who did not receive the multidisciplinary treatment.


Treatment for liver cancer includes surgical treatment, such as liver resection and laparoscopic liver resection, and interventional procedures, such as radiofrequency ablation therapy (RFA), cryoablation therapy, microwave ablation, transarterial chemoembolization (TACE), and transarterial radioembolization (TARE), as well as radiation therapy, chemo therapy, targeted agents, immune-modulating agents, liver transplantation, and proton therapy. There is a variety of procedural options for liver cancer, and treatment can be performed in various combinations. In such complex situations, multidisciplinary team approach, in which doctors of various departments cooperate to present directions of treatment, is more likely to offer personalized and optimized treatment for each patient. This study was published in a recent issue of international journal Plos one.


Other Articles